Germline mutations in the TP53 gene
- PMID: 8718514
Germline mutations in the TP53 gene
Abstract
Since the majority of germline mutations in the TP53 gene seem to occur in LFS or LFL families, and these are rare, research is best conducted in a collaborative setting (Li and Fraumeni, in press). In a report from a meeting at Bethesda in 1993, the following areas were outlined for collaborative study: the correlation (if any) of phenotypes with specific mutation; age specific penetrance; cumulative cancer incidence; gender differences in tumour development in carriers; the effects of DNA damaging agents on individuals with a TP53 mutation; the frequency of TP53 germline mutations in cohorts of patients with rare childhood tumours (eg adrenocortical carcinoma); and the psychosocial aspects of predictive TP53 testing. In addition, if, as seems likely from recent data, X irradiation in these individuals induces DNA damage that is tolerated, urgent collaborative studies are needed to investigate new methods of screening, such as magnetic resonance imaging. Treatment modalities should be carefully chosen, and for this reason alone, predictive testing may be desirable in all LFS and LFL families. Individuals carrying TP53 mutations could be offered chemoprevention within trials in an effort to reduce their mortality from cancer.
Similar articles
-
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429. J Med Genet. 2010. PMID: 20522432
-
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.Cancer Res. 2003 Oct 15;63(20):6643-50. Cancer Res. 2003. PMID: 14583457
-
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.Cancer Res. 1997 Aug 1;57(15):3245-52. Cancer Res. 1997. PMID: 9242456
-
Germline TP53 mutations and Li-Fraumeni syndrome.Hum Mutat. 2003 Mar;21(3):313-20. doi: 10.1002/humu.10185. Hum Mutat. 2003. PMID: 12619118 Review.
-
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Curr Opin Oncol. 2010. PMID: 19952748 Review.
Cited by
-
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Mol Diagn Ther. 2013 Feb;17(1):31-47. doi: 10.1007/s40291-013-0020-0. Mol Diagn Ther. 2013. PMID: 23355100 Free PMC article. Review.
-
Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.BMC Cancer. 2012 Jun 12;12:237. doi: 10.1186/1471-2407-12-237. BMC Cancer. 2012. PMID: 22691290 Free PMC article.
-
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Cancer. 2012 Feb 15;118(4):908-13. doi: 10.1002/cncr.26377. Epub 2011 Jul 14. Cancer. 2012. PMID: 21761402 Free PMC article.
-
Molecular insights into TP53 mutation (p. Arg267Trp) and its connection to Choroid Plexus Carcinomas and Li-Fraumeni Syndrome.Genes Genomics. 2024 Aug;46(8):941-953. doi: 10.1007/s13258-024-01531-9. Epub 2024 Jun 19. Genes Genomics. 2024. PMID: 38896352
-
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.NPJ Genom Med. 2016 Jan 13;1:15003. doi: 10.1038/npjgenmed.2015.3. eCollection 2016. NPJ Genom Med. 2016. PMID: 29263802 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous